This is relevant as CD4+ Th1 lymphocytes, through production IFN-γ, enhance anti-tumoral response in HCC and accordingly, a significant decrease of CD4+ Th1-cells in patients with liver cirrhosis and HCC has been reported, highlighting their importance in liver cancer biology [186,187]. This evidence concerns the gene CD4 and liver cancer.